Population pharmacokinetics of piperaquine after two different treatment regimens with dihydroartemisinin-piperaquine in patients with Plasmodium falciparum malaria in Thailand.
about
Dihydroartemisinin/Piperaquine: a review of its use in the treatment of uncomplicated Plasmodium falciparum malariaeditDihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malariaArtemisinin combination therapy for vivax malariaModelling the impact of artemisinin combination therapy and long-acting treatments on malaria transmission intensityThe use of artemether-lumefantrine for the treatment of uncomplicated Plasmodium vivax malariaEfficacy of two versus three-day regimens of dihydroartemisinin-piperaquine for uncomplicated malaria in military personnel in northern Cambodia: an open-label randomized trialEfficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquinePopulation Pharmacokinetic Properties of Piperaquine in Falciparum Malaria: An Individual Participant Data Meta-Analysis.Safety and efficacy of dihydroartemisinin-piperaquine in falciparum malaria: a prospective multi-centre individual patient data analysis.Population pharmacokinetic assessment of the effect of food on piperaquine bioavailability in patients with uncomplicated malaria.Treatment of asymptomatic carriers with artemether-lumefantrine: an opportunity to reduce the burden of malaria?Optimizing the programmatic deployment of the anti-malarials artemether-lumefantrine and dihydroartemisinin-piperaquine using pharmacological modelling.Selection of known Plasmodium falciparum resistance-mediating polymorphisms by artemether-lumefantrine and amodiaquine-sulfadoxine-pyrimethamine but not dihydroartemisinin-piperaquine in Burkina FasoComparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria.Population Pharmacokinetics and Antimalarial Pharmacodynamics of Piperaquine in Patients With Plasmodium vivax Malaria in ThailandInterspecies allometric scaling of antimalarial drugs and potential application to pediatric dosing.Efficacy and safety of artemisinin combination therapy (ACT) for non-falciparum malaria: a systematic review.Modelling the time course of antimalarial parasite killing: a tour of animal and human models, translation and challengesEffect of nutritional status on response to treatment with artemisinin-based combination therapy in young Ugandan children with malariaPharmacokinetic predictors for recurrent malaria after dihydroartemisinin-piperaquine treatment of uncomplicated malaria in Ugandan infantsFitness cost of resistance for lumefantrine and piperaquine-resistant Plasmodium berghei in a mouse model.Piperaquine resistance is associated with a copy number variation on chromosome 5 in drug-pressured Plasmodium falciparum parasites.In vivo efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria in Central Ethiopia.A small amount of fat does not affect piperaquine exposure in patients with malaria.Mass campaigns with antimalarial drugs: a modelling comparison of artemether-lumefantrine and DHA-piperaquine with and without primaquine as tools for malaria control and elimination.Pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated falciparum malaria.Pharmacokinetics of piperaquine transfer into the breast milk of Melanesian mothers.Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria.Ex vivo activity of the ACT new components pyronaridine and piperaquine in comparison with conventional ACT drugs against isolates of Plasmodium falciparum.Population pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated malaria.Plasmodium falciparum dihydroartemisinin-piperaquine failures in Cambodia are associated with mutant K13 parasites presenting high survival rates in novel piperaquine in vitro assays: retrospective and prospective investigations.Artemisinin-naphthoquine combination therapy for uncomplicated pediatric malaria: a pharmacokinetic study.Pharmacokinetic comparison of two piperaquine-containing artemisinin combination therapies in Papua New Guinean children with uncomplicated malaria.Altering Antimalarial Drug Regimens May Dramatically Enhance and Restore Drug Effectiveness.Pharmacokinetics of piperaquine in pregnant women in Sudan with uncomplicated Plasmodium falciparum malariaOptimal designs for population pharmacokinetic studies of the partner drugs co-administered with artemisinin derivatives in patients with uncomplicated falciparum malariaVariable piperaquine exposure significantly impacts protective efficacy of monthly dihydroartemisinin-piperaquine for the prevention of malaria in Ugandan children.Treatment outcomes in a safety observational study of dihydroartemisinin/piperaquine (Eurartesim(®)) in the treatment of uncomplicated malaria at public health facilities in four African countries.Assessing the utility of an anti-malarial pharmacokinetic-pharmacodynamic model for aiding drug clinical development.A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Sudan.
P2860
Q21032449-4C781657-3EB2-45CC-8A17-46E561E847C7Q24201077-3D65AB4C-014C-49B1-9248-30CD68297C9FQ24622539-2991361C-F48C-46E0-B573-2D853D8A4615Q28474141-207759C7-6F83-421C-A109-91339DE60036Q28478579-C557951D-DC74-41F0-8C8C-E972121A0A11Q28541521-0755FAD9-662F-4D46-9144-30E3C9642A25Q28542034-3695D509-733D-4CCE-B8F7-0D712B979104Q31153944-6FD64BFA-9108-41E6-AFBA-463D1F5A7DF5Q33489551-2F77EABF-0A1A-4E73-AEDD-8AD41CE4544AQ33622892-50EF8E99-BDEA-456F-BB5F-6188C0822643Q33670134-5347BE6A-D052-43DA-81D5-AE661FED7D33Q33678483-24204613-A832-40D0-BC54-C5C7E36DCB49Q33826359-5725118D-2FCE-40B9-B993-58877B268CA0Q33903438-D9B688DE-99F9-4BAD-8C7D-FF1F3A15EA41Q34116219-58EE1F36-A0FE-4552-A252-B1DDE20C549FQ34299078-B9AD30DE-DAE2-4226-8338-578B6F115DEDQ34646141-743765F9-D737-47F8-A8D9-7BE633B651F6Q34953705-65F8F4B9-84B3-445B-A3EF-9D2E41680DD1Q35004867-0CA94E02-9425-493F-82CA-677C75986AC2Q35055212-3CFB9F56-0280-4550-AD55-E6FC4B5A8B39Q35107675-C8C09499-2005-402A-8817-5698F08DD910Q35139505-7C3E924A-F07F-4659-AAFC-8E40CA7F0007Q35186075-977D8782-5073-4C69-A632-80A953FBB869Q35191426-12C0D934-0F9F-4527-A362-19713DED8ED8Q35224221-3379FCAB-46F6-44C3-98A4-F873926E5EB3Q35598379-D049EFBD-355B-4751-AA4B-0C80633268ECQ35746024-E71EBA5E-6EC5-465E-9E05-DB82017885EDQ35806356-5BD97189-4111-41D5-95ED-29E8EA975AFAQ35834198-DE2D36A5-4C54-4E8E-918B-2A5B487D25E0Q35867343-86C1E2C5-1BC1-4255-809D-9AA372CF498CQ35875707-4FBAF730-CDB0-44BF-84E2-CF36442563A1Q35941440-08BA4DC8-6800-4CBE-94D3-CFFF7706715AQ36018642-E4F46EAA-DE64-42B9-A492-DB574D5F794EQ36075783-DF3AE9BD-F35E-4F99-8D71-C36C7605596AQ36080121-E9264E8F-ED72-489E-BE14-484248358632Q36088256-3CB26D51-C779-48D2-B15E-299FE2154BA2Q36092227-039E7161-4B73-4A24-8AFD-2A93CD50A844Q36508726-B60718BE-26A5-49D1-A044-FA5856747EFFQ36539049-C700EFE5-4800-47B5-A40A-EBE511CF0FB7Q36552289-CA25EB54-5A8D-417F-BA48-FB2B092F679E
P2860
Population pharmacokinetics of piperaquine after two different treatment regimens with dihydroartemisinin-piperaquine in patients with Plasmodium falciparum malaria in Thailand.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Population pharmacokinetics of ...... alciparum malaria in Thailand.
@ast
Population pharmacokinetics of ...... alciparum malaria in Thailand.
@en
type
label
Population pharmacokinetics of ...... alciparum malaria in Thailand.
@ast
Population pharmacokinetics of ...... alciparum malaria in Thailand.
@en
prefLabel
Population pharmacokinetics of ...... alciparum malaria in Thailand.
@ast
Population pharmacokinetics of ...... alciparum malaria in Thailand.
@en
P2093
P2860
P50
P921
P356
P1476
Population pharmacokinetics of ...... alciparum malaria in Thailand.
@en
P2093
E A Ashley
K Stepniewska
L Phaiphun
N Lindegardh
P2860
P304
P356
10.1128/AAC.00955-07
P407
P577
2008-01-07T00:00:00Z